<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Unity Biotechnology, Inc.

    Unity Biotechnology, Inc.

    UNITY Biotechnology is developing therapeutics to extend human healthspan by slowi...

    UNITY Biotechnology is developing therapeutics ...

    Filing Type:    PU
    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals, Inc.

    Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on a...

    Concert Pharmaceuticals is a clinical stage bio...

    Filing Type:    PU
    Masimo Corporation

    Masimo Corporation

    We are a global medical technology company that develops, manufactures, and market...

    We are a global medical technology company that...

    Filing Type:    PU
    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc.

    RTI Surgical Holdings, Inc. is a leading global surgical implant company providing...

    RTI Surgical Holdings, Inc. is a leading global...

    Filing Type:    PU
    CRISPR Therapeutics AG

    CRISPR Therapeutics AG

    We are rapidly translating our specific, efficient and versatile CRISPR/Cas9 gene-...

    We are rapidly translating our specific, effici...

    Filing Type:    PU
    Quanterix Corporation

    Quanterix Corporation

    Quanterix is a company that is digitizing biomarker analysis with the goal of adva...

    Quanterix is a company that is digitizing bioma...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Guardant Health, Inc.

    Guardant Health, Inc.

    We are a leading precision oncology company focused on helping conquer cancer glob...

    We are a leading precision oncology company foc...

    Filing Type:    PU
    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc.

    Stemline Therapeutics, Inc. is a commercial-stage biopharmaceutical company focuse...

    Stemline Therapeutics, Inc. is a commercial-sta...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.